We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 8,835 results
  1. Mammalian target of rapamycin inhibition protects glioma cells from temozolomide-induced cell death

    Glioblastoma is an incurable brain tumor with a median survival below two years. Trials investigating targeted therapy with inhibitors of the kinase...

    Benedikt Sauer, Nadja I. Lorenz, ... Michael W. Ronellenfitsch in Cell Death Discovery
    Article Open access 05 January 2024
  2. Hydrogen peroxide modulates the expression of the target of rapamycin (TOR) and cell division in Arabidopsis thaliana

    Hydrogen peroxide (H 2 O 2 ) is naturally produced by plant cells during normal development and serves as a messenger that regulates cell metabolism....

    Alma Alejandra Hernández-Esquivel, Jorge Alejandro Torres-Olmos, ... Ernesto García-Pineda in Protoplasma
    Article 28 May 2024
  3. Blazing a trail for the clinical use of rapamycin as a geroprotecTOR

    Treatment with rapamycin, an inhibitor of the mechanistic Target Of Rapamycin Complex One (mTORC1) protein kinase, has been repeatedly demonstrated...

    Adam R. Konopka, Dudley W. Lamming, ... Alexey Terskikh in GeroScience
    Article 06 October 2023
  4. Evaluation of off-label rapamycin use on oral health

    Rapamycin (sirolimus) is an FDA approved drug with immune modulating properties that is being prescribed off-label in adults as a preventative...

    Johnny Hudson, Tammi Kaeberlein, ... Jonathan Y. An in GeroScience
    Article 06 June 2024
  5. Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling

    Biliary atresia (BA) is a cholestatic liver disease in neonates with devastating obstructive intrahepatic and extrahepatic biliary ducts. Owing to...

    **nbei Tian, Ying Wang, ... Yongtao **ao in Cell Death & Disease
    Article Open access 26 November 2022
  6. Rapamycin Inhibits Senescence and Improves Immunomodulatory Function of Mesenchymal Stem Cells Through IL-8 and TGF-β Signaling

    Mesenchymal stromal cells (MSCs) grown in high-density monolayers (sheets) are promising vehicles for numerous bioengineering applications. When MSC...

    Aaron J Sheppard, Kristin Delgado, ... Richard S Barton in Stem Cell Reviews and Reports
    Article Open access 10 February 2024
  7. Rapamycin protects mouse skin from ultraviolet B-induced photodamage by modulating Hspb2-mediated autophagy and apoptosis

    Background

    Continuous exposure to UVB is the main extrinsic cause of skin photodamage, which is associated with oxidative stress, DNA damage,...

    Ang Li, Ai-Jun Chen, ... ** Wang in Molecular Biology Reports
    Article 06 January 2024
  8. Evaluation of off-label rapamycin use to promote healthspan in 333 adults

    Rapamycin (sirolimus) is an FDA-approved drug with immune-modulating and growth-inhibitory properties. Preclinical studies have shown that rapamycin...

    Tammi L. Kaeberlein, Alan S. Green, ... Matt Kaeberlein in GeroScience
    Article 16 May 2023
  9. Rapamycin Regulates Lipopolysaccharide-Induced Microglial Phagocytosis In Vitro

    Abstract

    Microglia phagocytosis plays an important role in the pathogenesis of neurodegeneration. Defects or dysfunction of microglia phagocytosis...

    S. J. Yang, J. L. Ying, W. J. **e in Molecular Biology
    Article 17 March 2024
  10. Screening the possible anti-cancer constituents of Hibiscus rosa-sinensis flower to address mammalian target of rapamycin: an in silico molecular docking, HYDE scoring, dynamic studies, and pharmacokinetic prediction

    One of the most common malignancies diagnosed and the leading cause of death for cancer-stricken women globally is breast cancer. The molecular...

    Hezha O. Rasul, Bakhtyar K. Aziz, ... Arif Kivrak in Molecular Diversity
    Article 01 November 2022
  11. Sexual identity of enterocytes regulates autophagy to determine intestinal health, lifespan and responses to rapamycin

    Pharmacological attenuation of mTOR presents a promising route for delay of age-related disease. Here we show that treatment of Drosophila with the...

    Jennifer C. Regan, Yu-Xuan Lu, ... Linda Partridge in Nature Aging
    Article Open access 01 December 2022
  12. Molecular and therapeutic insights of rapamycin: a multi-faceted drug from Streptomyces hygroscopicus

    The advancement in pharmaceutical research has led to the discovery and development of new combinatorial life-saving drugs. Rapamycin is a macrolide...

    Sanjeev K. Ganesh, C. Subathra Devi in Molecular Biology Reports
    Article 25 January 2023
  13. Rapamycin restores peripheral blood flow in aged mice and in mouse models of atherosclerosis and Alzheimer’s disease

    Peripheral artery disease (PAD), defined as reduced blood flow to the lower limbs, is a serious disorder that can lead to loss of function in the...

    Candice E. Van Skike, Nicholas DeRosa, ... Stacy A. Hussong in GeroScience
    Article 13 April 2023
  14. Mechanistic target of rapamycin complex 1 orchestrates the interplay between hepatocytes and Kupffer cells to determine the outcome of immune-mediated hepatitis

    The cell-cell interaction between hepatocytes and Kupffer cells (KCs) is crucial for maintaining liver homeostasis, and the loss of KCs and...

    **aoli Sun, Yajie Ni, ... Chunsun Dai in Cell Death & Disease
    Article Open access 09 December 2022
  15. Long-lasting geroprotection from brief rapamycin treatment in early adulthood by persistently increased intestinal autophagy

    The licensed drug rapamycin has potential to be repurposed for geroprotection. A key challenge is to avoid adverse side effects from continuous...

    Paula Juricic, Yu-Xuan Lu, ... Linda Partridge in Nature Aging
    Article Open access 29 August 2022
  16. Target of rapamycin (TOR) gene is vital for whitefly survival and reproduction

    The whitefly Bemisia tabaci (Gennadius) is a devastating polyphagous pest that causes significant losses in several economically important crops...

    Heena Puri, Vikas **dal in Journal of Biosciences
    Article 21 June 2021
  17. Crossregulation of rapamycin and elaiophylin biosynthesis by RapH in Streptomyces rapamycinicus

    Abstract

    Rapamycin is an important macrocyclic antibiotic produced by Streptomyces rapamycinicus . In the rapamycin biosynthetic gene cluster (BGC),...

    Wenyan He, Wenfang Wang, ... Yinhua Lu in Applied Microbiology and Biotechnology
    Article 26 February 2022
  18. Loss of TTC17 promotes breast cancer metastasis through RAP1/CDC42 signaling and sensitizes it to rapamycin and paclitaxel

    Background

    Breast cancer (BC) metastasis is the leading cause of poor prognosis and therapeutic failure. However, the mechanisms underlying cancer...

    **gyao Zhang, Fengzhu Guo, ... Haili Qian in Cell & Bioscience
    Article Open access 09 March 2023
  19. Target Deconvolution by Limited Proteolysis Coupled to Mass Spectrometry

    Limited proteolysis coupled to mass spectrometry (LiP-MS) is a recent proteomics technique that allows structure-based target engagementTarget...
    Viviane Reber, Matthias Gstaiger in Chemogenomics
    Protocol 2023
  20. A cocktail of rapamycin, acarbose, and phenylbutyrate prevents age-related cognitive decline in mice by targeting multiple aging pathways

    Aging is a primary risk factor for cognitive impairment and exacerbates multiple biological processes in the brain, including but not limited to...

    Zhou Jiang, Qianpei He, ... Warren Ladiges in GeroScience
    Article Open access 16 May 2024
Did you find what you were looking for? Share feedback.